Beviglia Cancer Models, LLC is a small, project-focused, “niche” preclinical cancer pharmacology CRO founded by a motivated scientist and entrepreneur to help pharmaceutical companies validate in vivo efficacy of proprietary cancer therapies. They are the perfect solution for the numerous start-ups working on in vitro drug discovery projects and for more established biopharma, including those built without a dedicated in vivo facility.

Our company offers a strong expertise in pharmacological modeling and experimental therapeutics in more clinically predictive models. Our extensive knowledge of in vivo systems ensures high quality and reproducible results. All our preclinical services are conducted with highly technical proficiency, scientific rigor, diligence, and compliance to approved SOPs and guidelines.

We are committed to work collaboratively with the clients on model selection, protocol improvement, study design and execution.